CSF2 and juvenile myelomonocytic leukemia: JMML is characterized by expansion of monocytic and granulocytic blood lineage and hypersensitivity to granulocyte-macrophage colony-stimulating factor (GM-CSF) (Emanuel et al., 1991; Niemeyer & Flotho, 2019).